Senior Vice-President, Business Development Operations at AstraZeneca
ABOUT THE SPEAKER
Shaun Grady is leading AstraZeneca’s transaction execution, due diligence and Alliance and Integration Management function. His job includes late-stage as well as on-market licensing and partnering, M&A, and divestments. His career background includes roles at ICI, Zeneca, and AstraZeneca in Corporate, Pharmaceuticals and US Legal departments, HR and Business Development. Shaun has worked on major projects including the AstraZeneca merger, creation of Avecia and Syngenta, acquisition of Cambridge Antibody Technology (CAT), MedImmune and Amylin, and the spin-out of Albireo.
ABOUT THE EVENT
Shaun will be speaking on "Understanding & working for/with a multinational company: Opportunity with AstraZeneca". We hope that this sharing will bring opportunities that students and academic researchers could tap into at AstraZeneca. You will hear about AstraZeneca on the global level, AstraZeneca in Cambridge, their role in the Cambridge life science ecosystem and how you can tap into opportunities at the company whether as a graduate, entrepreneur or as a researcher. More information can be found at the event page
Who could benefit from this event?
-
Anyone (Wolfson and Non-Wolfson Members) interested in business and sciences
-
From scientists to sales, lab techs to legal.
-
Anyone who would like to consider a career with any multinational company or pharmaceutical/biopharmaceutical company.
-
A researcher who would like to know about a potential partnership with AstraZeneca
-
An entrepreneur with ideas that could disrupt emerging markets.
-
An entrepreneur who would love to understand opportunities entrepreneurs have with AstraZeneca
-
Anyone with interest in AstraZeneca, and the science of drug discovering and disease control
